Ophthalmic Consultants of Boston — Boston, Massachusetts

Public research footprint of Ophthalmic Consultants of Boston, compiled from the ClinicalTrials.gov public registry.

148

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Geographic Atrophy · Neovascular Age-related Macular Degeneration · Wet Age-related Macular Degeneration · NSCLC (Non-small Cell Lung Cancer)

Recently updated registry entries

NCT05210803 — Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for… (Enrolling By Invitation)
NCT05296447 — Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for… (Enrolling By Invitation)
NCT06668064 — A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ophthalmic Consultants of Boston?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.